Lansoprazole

gastrin ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27891632 Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials. 2017 Jan 1
2 25185672 Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes. 2014 1
3 20585936 Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. 2010 Oct 3
4 19304401 Proton pump inhibitors as a treatment method for type II diabetes. 2009 Jul 1
5 19318694 Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects. 2009 Apr 1
6 19568178 Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study. 2009 Aug 1
7 12677149 Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans. 2003 Apr 1
8 12189558 Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. 2002 Aug 27 1
9 11136283 Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. 2001 Jan 1
10 11004817 [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)]. 2000 Sep 1
11 10440603 Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects. 1999 Jun 2
12 9068463 Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. 1997 Mar 1
13 9190140 Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa. 1997 May 3
14 8792694 Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. 1996 Sep 1
15 8804870 Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine. 1996 May 1
16 8853756 Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. 1996 Aug 1
17 7639232 Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. 1995 Aug 1
18 8751234 Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C. 1995 Sep-Oct 2
19 7918926 Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. 1994 Jun 2
20 8053433 Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. 1994 Aug 1
21 8101695 Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. 1993 Aug 1
22 8349067 [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial]. 1993 1
23 8490080 An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. 1993 1
24 1600052 The effects of lansoprazole, a new H+,K(+)-ATPase inhibitor, on gastric pH and serum gastrin. 1992 Jun 2